Skip to main content

Table 1 Clinical characteristics of the cohort of 1038 women with ongoing postpartum haemorrhage included in this analysis

From: Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study

Patients

n = 1038

Maternal characteristics

 Age (years)

31.0 (28.0–35.0)a

 BMI (kg/m2)

23.2 (21.0–26.3)

 Ethnicity Caucasian

747 (72%)b

 Nulliparity

534 (51%)

 Gestational age

39.7 (38.1–40.7)

Mode of birth

 Caesarean section

254 (24%)

 Vaginal

780 (75%)

Comorbidity

 Pre-eclampsia/ HELLP

104 (10%)

 Anti-coagulant use

6 (0.6%)

Transfer to hospital

 No transfer (birth in hospital)

753 (73%)

 Transfer to hospital during labour

157 (15%)

 Postpartum transfer (birth at home)

128 (12%)

Primary cause of bleeding

 Uterine atony

684 (66%)

 Retained placenta

168 (16%)

 Pathological ingrowth of placenta

89 (9%)

 Surgical bleeding and abruption/coagulopathy

97(9%)

Placentation

 Abnormal localisation placenta

65 (6%)

 Pathological ingrowth placenta

97 (9%)

Composite endpoint severe maternal morbidity and mortality

355 (34%)

 Embolisation

124 (12%)

 Hysterectomy

57 (5%)

 Emergency B-Lynch

27 (3%)

 Ligation arteries

7 (0.7%)

 ICU admission

295 (28%)

 Maternal mortality

6 (0.6%)

Haemostatic interventions

 Fibrinogen administered

98 (9%)

 Tranexamic acid administered

473 (46%)

 Recombinant FVIIa administered

29 (3%)

Bleeding characteristics

 Bleeding rate (ml/min) c

2.4 (1.3–4.8)

 Shock

927 (89%)

 Total volume blood loss (L)

3.0 (2.5–4.0)

 Total volume of clear fluids (L)

3.0 (2.0–4.0)

 Total units of blood products (n)

6.0 (4.0–8.0)

  1. aValues are presented as median with (interquartile range), bpercentage, c maximum